{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T03:36:31Z","timestamp":1649129791053},"reference-count":29,"publisher":"University of Tokushima Faculty of Medicine","issue":"1.2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2021]]},"DOI":"10.2152\/jmi.68.196","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T22:12:19Z","timestamp":1621030339000},"page":"196-201","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement"],"prefix":"10.2152","volume":"68","author":[{"given":"Mamiko","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Sumitani","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyori","family":"Kawata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Oura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Sogabe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Miki","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Kagawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingen","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Boehme V, Zeynalova S, Kloess M, Loeffler M, Kaiser U, Pfreundschuh M, Schmitz N\u2005:\u2005Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL). Ann Oncol 18(1)\u2005:\u2005149-157, 2007","DOI":"10.1093\/annonc\/mdl327"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zinzani PL, Magagnoli M, Frezza G, Prologo G, Gherlinzoni F, Bendandi M, Albertini P, Babini L, D\u2019Alessandro R, Tura S\u2005:\u2005Isolated central nervous system relapse in aggressive non-Hodgkin\u2019s lymphoma\u2005:\u2005the Bologna experience. Leuk Lymphoma 32(5-6)\u2005:\u2005571-576, 1999","DOI":"10.3109\/10428199909058415"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Graham MS, DeAngelis LM\u2005:\u2005Improving outcomes in primary CNS lymphoma. Best practice & research Clinical haematology 31(3)\u2005:\u2005262-269, 2018","DOI":"10.1016\/j.beha.2018.07.006"},{"key":"4","unstructured":"4. Strong JM, Collins JM, Lester C, Poplack DG\u2005:\u2005Pharmacokinetics of intraventricular and intravenous N,N\u2019,N\u2019\u2019-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res 46(12 Pt 1)\u2005:\u20056101-6104, 1986"},{"key":"5","unstructured":"5. Hassan M, Ehrsson H, Smedmyr B, Totterman T, Wallin I, Oberg G, Simonsson B\u2005:\u2005Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy. Bone Marrow Transplant 4(1)\u2005:\u2005113-114, 1989"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ciurea SO, Andersson BS\u2005:\u2005Busulfan in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15(5)\u2005:\u2005523-536, 2009","DOI":"10.1016\/j.bbmt.2008.12.489"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cheng T, Forsyth P, Chaudhry A, Morris D, Gluck S, Russell JA, Stewart DA\u2005:\u2005High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma. Bone Marrow Transplant 31(8)\u2005:\u2005679-685, 2003","DOI":"10.1038\/sj.bmt.1703917"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Montemurro M, Kiefer T, Schuler F, Al-Ali HK, Wolf HH, Herbst R, Haas A, Helke K, Theilig A, Lotze C, Hirt C, Niederwieser D, Schwenke M, Kruger WH, Dolken G\u2005:\u2005Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan\u2009\/\u2009thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy\u2005:\u2005results of the multicenter Ostdeutsche Studiengruppe Hamato-Onkologie OSHO-53 phase II study. Ann Oncol 18(4)\u2005:\u2005665-671, 2007","DOI":"10.1093\/annonc\/mdl458"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Santos EC, Sessions J, Hutcherson D, Flowers C, Langston A, Waller EK\u2005:\u2005Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation--a similar experience. Biol Blood Marrow Transplant 13(6)\u2005:\u2005746-747, 2007","DOI":"10.1016\/j.bbmt.2007.02.006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Alimohamed N, Daly A, Owen C, Duggan P, Stewart DA\u2005:\u2005 Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma\u2005:\u2005a single centre experience. Leuk Lymphoma 53(5)\u2005:\u2005862-867, 2012","DOI":"10.3109\/10428194.2011.633250"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cote GM, Hochberg EP, Muzikansky A, Hochberg FH, Drappatz J, McAfee SL, Batchelor TT, LaCasce AS, Fisher DC, Abramson JS, Armand P, Chen YB\u2005:\u2005Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma. Biol Blood Marrow Transplant 18(1)\u2005:\u200576-83, 2012","DOI":"10.1016\/j.bbmt.2011.07.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Soussain C, Choquet S, Fourme E, Delgadillo D, Bouabdallah K, Ghesquieres H, Damaj G, Dupriez B, Vargaftig J, Gonzalez A, Houillier C, Taillandier L, Hoang-Xuan K, Leblond V\u2005:\u2005Intensive chemotherapy with thiotepa, busulfan and cyclophosphamide and hematopoietic stem cell rescue in relapsed or refractory primary central nervous system lymphoma and intraocular lymphoma: a retrospective study of 79 cases. Haematologica 97(11)\u2005:\u20051751-1756, 2012","DOI":"10.3324\/haematol.2011.060434"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kiefer T, Hirt C, Spath C, Schuler F, Al-Ali HK, Wolf HH, Herbst R, Maschmeyer G, Helke K, Kessler C, Niederwieser D, Busemann C, Schroeder H, Vogelgesang S, Kirsch M, Montemurro M, Kruger WH, Dolken G\u2005:\u2005Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II study. Ann Oncol 23(7)\u2005:\u20051809-1812, 2012","DOI":"10.1093\/annonc\/mdr553"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Choi MK, Kang ES, Kim DW, Ko YH, Seok H, Park JH, Pyo DH, Hoon Lim D, Kim SJ, Kim WS\u2005:\u2005Treatment outcome of relapsed\u2009\/\u2009refractory primary central nervous system diffuse large B-cell lymphoma\u2005:\u2005a single-center experience of autologous stem cell transplantation. Int J Hematol 98(3)\u2005:\u2005346-354, 2013","DOI":"10.1007\/s12185-013-1403-z"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Welch MR, Sauter CS, Matasar MJ, Faivre G, Weaver SA, Moskowitz CH, Omuro AM\u2005:\u2005Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide. Leuk Lymphoma 56(2)\u2005:\u2005361-367, 2015","DOI":"10.3109\/10428194.2014.916800"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chen YB, Batchelor T, Li S, Hochberg E, Brezina M, Jones S, Del Rio C, Curtis M, Ballen KK, Barnes J, Chi AS, Dietrich J, Driscoll J, Gertsner ER, Hochberg F, LaCasce AS, McAfee SL, Spitzer TR, Nayak L, Armand P\u2005:\u2005Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma. Cancer 121(2)\u2005:\u2005226-233, 2015","DOI":"10.1002\/cncr.29023"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lee MY, Kim HS, Lee JY, Lim SH, Kang ES, Ko YH, Kim SJ, Kim WS\u2005:\u2005Efficacy and feasibility of autologous stem cell transplantation in patients with diffuse large Bcell lymphoma with secondary central nervous system involvement. Int J Hematol 102(6)\u2005:\u2005678-688, 2015","DOI":"10.1007\/s12185-015-1874-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Omuro A, Correa DD, DeAngelis LM, Moskowitz CH, Matasar MJ, Kaley TJ, Gavrilovic IT, Nolan C, Pentsova E, Grommes CC, Panageas KS, Baser RE, Faivre G, Abrey LE, Sauter CS\u2005:\u2005R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood 125(9)\u2005:\u20051403-1410, 2015","DOI":"10.1182\/blood-2014-10-604561"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Oh DH, Chua N, Street L, Stewart DA\u2005:\u2005Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan\u2009\/\u2009thiotepa-based conditioning and autologous stem cell transplant. Leuk Lymphoma 57(1)\u2005:\u200528-33, 2016","DOI":"10.3109\/10428194.2015.1026901"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Qualls D, Sullivan A, Li S, Brunner AM, Collier K, Hochberg E, Armand P, Batchelor TT, Chen YB, DeFilipp Z\u2005:\u2005High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement. Clinical lymphoma, myeloma & leukemia 17(12)\u2005:\u2005884-888, 2017","DOI":"10.1016\/j.clml.2017.08.100"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Doorduijn JK, van Imhoff GW, van der Holt B, Schouten HC, Schaafsma MR, MacKenzie MA, Baars JW, Kersten MJ, Lugtenburg PJ, van den Bent MJ, Enting RH, Spoelstra FM, Poortmans P, Bromberg JEC\u2005:\u2005Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation\u2005:\u2005results of the HOVON 80 phase 2 study. Hematol Oncol 35(4)\u2005:\u2005497-503, 2017","DOI":"10.1002\/hon.2342"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Scordo M, Morjaria SM, Littmann ER, Bhatia A, Chung HH, Maloy M, DeAngelis LM, Giralt SA, Taur Y, Sauter CS\u2005:\u2005Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation. Biol Blood Marrow Transplant 24(9)\u2005:\u20051914-1919, 2018","DOI":"10.1016\/j.bbmt.2018.04.013"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. DeFilipp Z, Li S, El-Jawahri A, Armand P, Nayak L, Wang N, Batchelor TT, Chen YB\u2005:\u2005High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission. Cancer 123(16)\u2005:\u20053073-3079, 2017","DOI":"10.1002\/cncr.30695"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hyung J, Hong JY, Yoon DH, Kim S, Park JS, Park CS, Lee SW, Kim JH, Ryu JS, Huh J, Suh C\u2005:\u2005Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma. Ann Hematol 98(7)\u2005:\u20051657-1664, 2019","DOI":"10.1007\/s00277-019-03667-1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yoon DH, Lee DH, Choi DR, Sohn BS, Kim S, Kim SW, Lee JS, Lee SW, Huh J, Suh C\u2005:\u2005Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma\u2005:\u2005a single-center experience. Bone Marrow Transplant 46(1)\u2005:\u2005105-109, 2011","DOI":"10.1038\/bmt.2010.71"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS\u2005:\u2005Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol 23(7)\u2005:\u20051507-1513, 2005","DOI":"10.1200\/JCO.2005.01.161"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Shin HJ, Lee WS, Lee HS, Kim H, Lee GW, Song MK, Kim JS, Yhim HY, Chung JS\u2005:\u2005Busulfan-containing conditioning regimens are optimal preparative regimens for autologous stem cell transplant in patients with diffuse large B-cell lymphoma. Leuk Lymphoma 55(11)\u2005:\u20052490-2496, 2014","DOI":"10.3109\/10428194.2014.882504"},{"key":"28","unstructured":"28. Teicher BA, Cucchi CA, Lee JB, Flatow JL, Rosowsky A, Frei E, 3rd\u2005:\u2005Alkylating agents\u2005:\u2005in vitro studies of cross-resistance patterns in human cell lines. Cancer Res 46(9)\u2005:\u20054379-4383, 1986"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ryu SG, Lee JH, Choi SJ, Lee JH, Lee YS, Seol M, Hur EH, Lee SH, Bae KS, Noh GJ, Lee MS, Yun SC, Han SB, Lee KH\u2005:\u2005Randomized comparison of four-times-daily versus once-daily intravenous busulfan in conditioning therapy for hematopoietic cell transplantation. Biol Blood Marrow Transplant 13(9)\u2005:\u20051095-1105, 2007","DOI":"10.1016\/j.bbmt.2007.06.005"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/68\/1.2\/68_196\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T05:53:28Z","timestamp":1623045208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/68\/1.2\/68_196\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":29,"journal-issue":{"issue":"1.2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.68.196","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}